Kuangli Bio-Tech Holdings Co (TPE:6431) Long-Term Debt: NT$6.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6431 Kuangli Bio-Tech Holdings Co Ltd TPE:6431
66 GF Score
Price NT$17.40
GF Value NT$11.64
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Kuangli Bio-Tech Holdings Co Long-Term Debt?

Kuangli Bio-Tech Holdings Co TPE:6431 +1.16% 66 Long-Term Debt is NT$6.2 Mil as of Dec. 2025. GuruFocus rates TPE:6431 with a GF Score™ of 66/100 and a GF Value™ of NT$11.64 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Kuangli Bio-Tech Holdings Co's Long-Term Debt for the quarter that ended in Dec. 2025 was NT$6.2 Mil.

Kuangli Bio-Tech Holdings Co's quarterly Long-Term Debt declined from Jun. 2025 (NT$9.3 Mil) to Sep. 2025 (NT$7.4 Mil) and declined from Sep. 2025 (NT$7.4 Mil) to Dec. 2025 (NT$6.2 Mil).

Kuangli Bio-Tech Holdings Co's annual Long-Term Debt declined from Dec. 2023 (NT$21.4 Mil) to Dec. 2024 (NT$6.2 Mil) and declined from Dec. 2024 (NT$6.2 Mil) to Dec. 2025 (NT$6.2 Mil).

Kuangli Bio-Tech Holdings Co  (TPE:6431) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Kuangli Bio-Tech Holdings Co Long-Term Debt Related Terms

Kuangli Bio-Tech Holdings Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Kuangli Bio-Tech Holdings Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kuangli Bio-Tech Holdings Co Long-Term Debt Chart

Kuangli Bio-Tech Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 12.18 21.38 6.25 6.17

Kuangli Bio-Tech Holdings Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.25 12.20 9.27 7.37 6.17
TPE:6431
66GF Score
Kuangli Bio-Tech Holdings Co Ltd TPE:6431
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$6.2 Mil mean?
Kuangli Bio-Tech Holdings Co (TPE:6431) has a Long-Term Debt of NT$6.2 Mil as of Dec. 2025.
Is Kuangli Bio-Tech Holdings Co's Long-Term Debt too high?
Kuangli Bio-Tech Holdings Co's current Long-Term Debt is NT$6.2 Mil. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's Long-Term Debt compare to PG and CL?
Kuangli Bio-Tech Holdings Co's Long-Term Debt of NT$6.2 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Consumer Packaged Goods company?
A good Long-Term Debt depends on the Consumer Packaged Goods industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Kuangli Bio-Tech Holdings Co's current Long-Term Debt is NT$6.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$11.64, compared to a current price of NT$17.40 — trading 49.5% above its estimated fair value. The current Long-Term Debt is NT$6.2 Mil. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current Long-Term Debt is NT$6.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?

Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued. The current stock price of NT$17.40 is trading 49.5% above its estimated GF Value™ of NT$11.64. GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.

Key valuation signals for TPE:6431:

  • Long-Term Debt: NT$6.2 Mil
  • GF Value™: NT$11.64 vs. price of NT$17.40 (49.5% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kuangli Bio-Tech Holdings Co Business Description

Address North Sound Road, Suite 102, Cannon Place, George Town, Grand Cayman, CYM
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
66GF Score

Get the complete analysis for TPE:6431

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.40
Price
NT$11.64
GF Value